These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30512651)

  • 1. [Should we prescribe statins for primary prevention of cardiovascular risk? Rather no].
    Lecerf JM
    Rev Prat; 2016 Mar; 66(3):334-337. PubMed ID: 30512651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Should we prescribe statins for primary prevention of cardiovascular risk? Rather yes].
    Béliard-Lasserre S
    Rev Prat; 2016 Mar; 66(3):332-334. PubMed ID: 30512650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
    Saib A; Sabbah L; Perdrix L; Blanchard D; Danchin N; Puymirat E
    Arch Cardiovasc Dis; 2013 Oct; 106(10):511-6. PubMed ID: 24080324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Statins in primary prevention of cardiovascular disease].
    Adham S; Miranda S; Doucet J; Lévesque H; Benhamou Y
    Rev Med Interne; 2018 Jan; 39(1):42-49. PubMed ID: 28866432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin therapy for primary prevention of cardiovascular disease.
    Taylor FC; Huffman M; Ebrahim S
    JAMA; 2013 Dec; 310(22):2451-2. PubMed ID: 24276813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Statins in secondary prevention of cardiovascular risk].
    Caussy C; Charrière S; Moulin P
    Rev Prat; 2016 Mar; 66(3):322-326. PubMed ID: 30512646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study.
    Yang Q; Zhong Y; Gillespie C; Merritt R; Bowman B; George MG; Flanders WD
    BMJ Open; 2017 Jan; 7(1):e011684. PubMed ID: 28119384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Statin intolerance].
    Graversen CB; Larsen ML; Schmidt EB
    Ugeskr Laeger; 2015 Aug; 177(36):. PubMed ID: 26324293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Statin therapy--for whom?].
    Kahri J; Syvänne M
    Duodecim; 2012; 128(8):811-8. PubMed ID: 22616372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What is the place of statins in the treatment of diabetes?].
    Cariou B
    Rev Prat; 2016 Mar; 66(3):328-329. PubMed ID: 30512648
    [No Abstract]   [Full Text] [Related]  

  • 12. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Statins with a perspective of lifelong therapy].
    Ertaş FS
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():29-36. PubMed ID: 19404048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing Cholesterol Treatment in Patients With Muscle Complaints.
    Rosenson RS; Baker S; Banach M; Borow KM; Braun LT; Bruckert E; Brunham LR; Catapano AL; Elam MB; Mancini GBJ; Moriarty PM; Morris PB; Muntner P; Ray KK; Stroes ES; Taylor BA; Taylor VH; Watts GF; Thompson PD
    J Am Coll Cardiol; 2017 Sep; 70(10):1290-1301. PubMed ID: 28859793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery calcium scoring in patients with statin associated muscle symptoms: Prescribing statins for those most likely to benefit.
    Orringer CE; Blaha MJ; Stone NJ
    J Clin Lipidol; 2021; 15(6):782-788. PubMed ID: 34688585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins: The Good, the Bad, and the Unexpected.
    Mager DR
    Home Healthc Now; 2016; 34(7):388-93. PubMed ID: 27348033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular prevention: lifestyle and statins--competitors or companions?
    Opie LH; Dalby AJ
    S Afr Med J; 2014 Mar; 104(3):168-73. PubMed ID: 24897816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS].
    Lavie G; Cohen S
    Harefuah; 2015 Jun; 154(6):382-6, 404. PubMed ID: 26281083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Benefits and risks for primary prevention with statins in the elderly].
    Joseph JP; Afonso M; Berdaï D; Salles N; Bénard A; Gay B; Bonnet F
    Presse Med; 2015 Dec; 44(12 Pt 1):1219-25. PubMed ID: 26585744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.